FIELD: immunology.
SUBSTANCE: invention relates to composition containing as the first component serogroup B N.meningitis outer membrane vesicle, and as the second one treatment immunogenic component associated with brain fever or other Nisseria infections.
EFFECT: immunotherapy for treatment of Nisseria infections with increased effectiveness.
9 cl, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
IMMUNISATION AGAINST CHLAMYDIA TRACHOMATIS | 2002 |
|
RU2331435C2 |
NEISSERIA ANTIGENE PEPTIDES | 2000 |
|
RU2281956C2 |
NEISSERIA ANTIGENIC PEPTIDES | 2000 |
|
RU2284332C2 |
NEISSERIA ANTIGENS | 1998 |
|
RU2347813C2 |
PROTEIN OBTAINED FROM NEISSERIA MENINGITIDIS ELICITING PROPERTIES OF ANTIGEN, ANTIBODY, NUCLEIC ACID (VARIANTS) AND COMPOSITION CONTAINING THEREOF | 2000 |
|
RU2233328C2 |
ANTIGEN MENINGOCOCCUS PEPTIDES (VARIANTS) | 2000 |
|
RU2253678C2 |
PROTEIN OBTAINED FROM NEISSERIA MENINGITIDIS SHOWING ANTIGEN PROPERTY, ANTIBODY, NUCLEIC ACID FRAGMENT (VARIANTS) AND COMPOSITION CONTAINING THEREOF | 1999 |
|
RU2233331C2 |
ANTIGENES NEISSERIA MENINGITIDIS | 1999 |
|
RU2343159C2 |
MENINGOCOCCAL fHBP POLYPEPTIDES | 2012 |
|
RU2567003C2 |
MENINGOCOCCAL fHBP POLYPEPTIDES | 2009 |
|
RU2475496C2 |
Authors
Dates
2006-07-20—Published
2001-01-17—Filed